On the recordMarch 9, 2000
It is pure profiteering, largely at taxpayer expense.
It is pure profiteering, largely at taxpayer expense.
Stark criticizes Amgen's price increase as unnecessary and exploitative.
Share
More from Pete Stark
turning a physician's decision to refer a patient into a marketable commodity.
I think we have to ask ourselves, how do we do more good than harm in eliminating the compensation arrangements.
What is shocking to me is that you want to spend even more than that and yet leave 30 million people without health care.